Page last updated: 2024-11-05

efloxate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

efloxate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8395
CHEMBL ID1349073
CHEBI ID31531
SCHEMBL ID309159
MeSH IDM0047039

Synonyms (83)

Synonym
coril
ccris 5253
efloxatum
rec 1-0185
domucor
((4-oxo-2-phenyl-4h-1-benzopyran-7-yl)oxy)acetic acid ethyl ester
efloxate
einecs 204-321-9
re 1-0185
corosanin
ethyl 7-flavonoxyacetate
flacethyle
efloxato [inn-spanish]
efloxate [inn:jan]
ethyl 7-hydroxyflavone
flavone-7-ethyl-oxyacetate
angorlisin
acetic acid, ((4-oxo-2-phenyl-4h-1-benzopyran-7-yl)oxy)-, ethyl ester
7-alpha-(acetoxyethane)-oxyflavone
oxiflavil
7-flavonoxyacetic acid ethyl ester
dilatan kore
ethyl flavon-7-yloxyacetate
brn 0313027
oxyflavil
eflossato [dcit]
ethyl-((4-oxo-2-phenyl-4h-1-benzopyran-7-yl)oxy) acetate
ethyl flavone-7-oxyacetate
7-flavone ethyl hydroxyacetate
recordil
IDI1_014413
OPREA1_663744
MLS000859001
smr000459180
ethyl 2-[(4-oxo-2-phenyl-4h-chromen-7-yl)oxy]acetate
119-41-5
D01135
efloxate (jan/inn)
MAYBRIDGE3_003026
HMS1439J12
ethyl 2-(4-oxo-2-phenylchromen-7-yl)oxyacetate
NCGC00182622-02
NCGC00182622-01
HMS3264O09
tox21_113177
cas-119-41-5
tox21_113178
dtxsid3048736 ,
dtxcid0028662
pharmakon1600-01504518
nsc758891
BRD-K55166090-001-07-4
HMS2787P19
CHEMBL1349073
nsc-758891
unii-czu6v3902k
4-18-00-00695 (beilstein handbook reference)
efloxato
czu6v3902k ,
eflossato
nsc 758891
efloxate [mi]
efloxate [inn]
efloxate [who-dd]
efloxate [jan]
efloxate [mart.]
CCG-213948
SCHEMBL309159
CS-4399
HY-B0930
AB00643675_07
AKOS030526077
sr-01000760674
SR-01000760674-2
CHEBI:31531
SBI-0207066.P001
ethyl 2-((4-oxo-2-phenyl-4h-chromen-7-yl)oxy)acetate
DB13333
Q962269
BRD-K55166090-001-03-3
NCGC00182622-03
F85196
MS-24824

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency35.48130.177814.390939.8107AID2147
LuciferasePhotinus pyralis (common eastern firefly)Potency19.12430.007215.758889.3584AID588342; AID624030
glp-1 receptor, partialHomo sapiens (human)Potency14.12540.01846.806014.1254AID624172
ClpPBacillus subtilisPotency31.62281.995322.673039.8107AID651965
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency10.00000.28189.721235.4813AID2326
aryl hydrocarbon receptorHomo sapiens (human)Potency14.96010.000723.06741,258.9301AID743085
Guanine nucleotide-binding protein GHomo sapiens (human)Potency7.07951.995325.532750.1187AID624287
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID640615Clearance in human liver microsomes at 1 uM measured after 60 mins by HPLC analysis2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (30.00)24.3611
2020's2 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]